We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$445M
1-Year Est. Return
41.72%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$366M
AUM Growth
+$71.8M
(+24%)
Cap. Flow
+$43.1M
Cap. Flow
% of AUM
11.79%
Top 10 Holdings %
Top 10 Hldgs %
41.16%
Holding
166
New
22
Increased
47
Reduced
25
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$8.54M |
| 2 |
ExxonMobil
XOM
|
+$8.27M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$4.58M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$4.05M |
| 5 |
Eli Lilly
LLY
|
+$3.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$2.47M |
| 2 |
Chemours
CC
|
+$1.08M |
| 3 |
Pfizer
PFE
|
+$740K |
| 4 |
Brookfield
BN
|
+$707K |
| 5 |
GE Aerospace
GE
|
+$450K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.37% |
| 2 | Technology | 16.92% |
| 3 | Healthcare | 13.29% |
| 4 | Industrials | 11.54% |
| 5 | Consumer Staples | 9.83% |
Similar funds
RWM
BI
WC
MLIC
AFA
SGCM
WCP
ACA
Searle & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Searle & Co held 166 positions worth $366M, up 24% from $294M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Searle & Co deployed $43.1M of net new capital in Q4 2023, opening 22 new positions and adding to 47 existing holdings. Its largest new stake was Fifth Third Bancorp: 165,037 shares worth $5.69M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $740K trimmed.
- Searle & Co's largest Q4 2023 buy was Fifth Third Bancorp: 165,037 shares worth $5.69M.
- Searle & Co added most to Procter & Gamble in Q4 2023, an estimated $8.54M increase.
- Searle & Co's biggest Q4 2023 reduction was Pfizer, cutting an estimated $740K.
- Searle & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $2.47M.
- Searle & Co's ten largest holdings make up 41% of its $366M portfolio in Q4 2023.
- Searle & Co opened 22 new positions and closed 7 in Q4 2023.
- Searle & Co's portfolio value rose 24% quarter-over-quarter to $366M.
Based on Searle & Co's 13F filing for Q4 2023, filed 6 Feb 2024.